Altered sleep architecture and higher incidence of subsyndromal depression in low endogenous melatonin secretors

  • Shadab Ataur Rahman
  • Shai Marcu
  • Leonid Kayumov
  • Colin Michael Shapiro
Original Paper


Melatonin secretion is synchronized to the sleep/wake cycle and has been suggested to have somnogenic properties. Sleep/wake cycle disruption and alterations in the secretary pattern of melatonin is present in various psychiatric disorders. The objective of this study was to investigate the sleep architecture and the presence of depression in individuals with low endogenous melatonin levels. The study included 16 participants (mean age 30.3 ± 14.9 years). The first night of testing included psychiatric evaluation followed by melatonin secretion profile evaluation by Dim Light Melatonin Onset test and then standard montage polysomnographic testing. On the second night, only polysomnographic testing was carried out with an imposed sleep period of 8 h. Low endogenous melatonin secretors (LEMS) showed no discernible peaks in melatonin secretion compared to normal secretors (controls). LEMS demonstrated significant alterations in rapid eye movement sleep but not in non-rapid eye movement sleep along with poor sleep initiation and quality compared to controls. 55.6% of the low melatonin secretors group presented with subsyndromal depression. Melatonin has significant bearing on sleep architecture and a lack of melatonin may desynchronize endogenous rhythms allowing subsyndromal depression to manifest.


Circadian rhythm disorder Subsyndromal depression Low melatonin Sleep architecture 


  1. 1.
    Bonnet M, Carskadon M, Easton P, Guilleminault C, Harper R, Hayes B, Hirshkowitz M, Ktonas P, Keenan S, Pressman M, Roehrs T, Smith J, Walsh J, Weber S, Westbrook P (1992) EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 15:173–184Google Scholar
  2. 2.
    Akerstedt T (2003) Shift work and disturbed sleep/wakefulness. Occup Med (Lond) 53:89–94CrossRefGoogle Scholar
  3. 3.
    Akerstedt T, Kecklund G, Knutsson A (1991) Spectral analysis of sleep electroencephalography in rotating three-shift work. Scand J Work Environ Health 17:330–336PubMedGoogle Scholar
  4. 4.
    American Psychiatric Association (1995) Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington, DCGoogle Scholar
  5. 5.
    Arendt J (2003) Importance and relevance of melatonin to human biological rhythms. J Neuroendocrinol 15:427–431PubMedCrossRefGoogle Scholar
  6. 6.
    Arendt J (2006) Melatonin and human rhythms. Chronobiol Int 23:21–37PubMedCrossRefGoogle Scholar
  7. 7.
    Avery DH, Wildschiodtz G, Smallwood RG, Martin D, Rafaelsen OJ (1986) REM latency and core temperature relationships in primary depression. Acta Psychiatr Scand 74:269–280PubMedCrossRefGoogle Scholar
  8. 8.
    Bonnet MH, Doghramji K, Roehrs T, Stepanski EJ, Sheldon SH, Walters AS, Wise M, Chesson AL Jr (2007) The scoring of arousal in sleep: reliability, validity, and alternatives. J Clin Sleep Med 3:133–145PubMedGoogle Scholar
  9. 9.
    Borbely AA, Wirz-Justice A (1982) Sleep, sleep deprivation and depression. A hypothesis derived from a model of sleep regulation. Hum Neurobiol 1:205–210PubMedGoogle Scholar
  10. 10.
    Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Baker G, Klassen TP, Vohra S (2005) The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med 20:1151–1158PubMedCrossRefGoogle Scholar
  11. 11.
    Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Vohra S, Klassen TP, Baker G (2006) Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ 332:385–393PubMedCrossRefGoogle Scholar
  12. 12.
    Cagnacci A (1997) Influences of melatonin on human circadian rhythms. Chronobiol Int 14:205–220PubMedCrossRefGoogle Scholar
  13. 13.
    Cajochen C, Krauchi K, Mori D, Graw P, Wirz-Justice A (1997) Melatonin and S-20098 increase REM sleep and wake-up propensity without modifying NREM sleep homeostasis. Am J Physiol 272:R1189–R1196PubMedGoogle Scholar
  14. 14.
    Cajochen C, Krauchi K, Wirz-Justice A (2003) Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol 15:432–437PubMedCrossRefGoogle Scholar
  15. 15.
    Claustrat B, Chazot G, Brun J, Jordan D, Sassolas G (1984) A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biol Psychiatry 19:1215–1228PubMedGoogle Scholar
  16. 16.
    Diagnostic Classification Steering Committee, Thorpy MJ, Chairman (1990) ICSD—International classification of sleep disorders: diagnostic and coding manual. American Sleep Disorders Association, Rochester, MNGoogle Scholar
  17. 17.
    Dijk DJ, Shanahan TL, Duffy JF, Ronda JM, Czeisler CA (1997) Variation of electroencephalographic activity during non-rapid eye movement and rapid eye movement sleep with phase of circadian melatonin rhythm in humans. J Physiol 505(Pt 3):851–858PubMedCrossRefGoogle Scholar
  18. 18.
    Doghramji K (2007) Melatonin and its receptors: a new class of sleep-promoting agents. J Clin Sleep Med 3:S17–S23PubMedGoogle Scholar
  19. 19.
    Drago F, Busa L, Benelli A, Bertolini A (1999) Acute low doses of melatonin stimulate rat sex behavior: the role of serotonin neurotransmission. Eur J Pharmacol 385:1–6PubMedCrossRefGoogle Scholar
  20. 20.
    Fleming JS, Courtney BE (1984) The dimensionality of self-esteem. II. Hierarchical facet model for revised measurement scales. J Pers Social Psychol 46:404–421CrossRefGoogle Scholar
  21. 21.
    Haimov I (2001) Melatonin rhythm abnormalities and sleep disorders in the elderly. CNS Spectr 6:502–506PubMedGoogle Scholar
  22. 22.
    Haimov I, Lavie P (1997) Melatonin—a chronobiotic and soporific hormone. Arch Gerontol Geriatr 24:167–173PubMedCrossRefGoogle Scholar
  23. 23.
    Haimov I, Lavie P, Laudon M, Herer P, Vigder C, Zisapel N (1995) Melatonin replacement therapy of elderly insomniacs. Sleep 18:598–603PubMedGoogle Scholar
  24. 24.
    Healy D, Waterhouse JM (1990) The circadian system and affective disorders: clocks or rhythms? Chronobiol Int 7:5–10 (discussion 11–24)PubMedCrossRefGoogle Scholar
  25. 25.
    Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC (1973) Quantification of sleepiness: a new approach. Psychophysiology 10:431–436PubMedCrossRefGoogle Scholar
  26. 26.
    Jindal RD, Thase ME (2004) Treatment of insomnia associated with clinical depression. Sleep Med Rev 8:19–30PubMedCrossRefGoogle Scholar
  27. 27.
    Johns MW (1992) Reliability and factor analysis of the Epworth sleepiness scale. Sleep 15:376–381PubMedGoogle Scholar
  28. 28.
    Johns MW (2000) Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res 9:5–11PubMedCrossRefGoogle Scholar
  29. 29.
    Judd LL, Rapaport MH, Paulus MP, Brown JL (1994) Subsyndromal symptomatic depression: a new mood disorder? J Clin Psychiatry 55(Suppl):18–28PubMedGoogle Scholar
  30. 30.
    Karadottir R, Axelsson J (2001) Melatonin secretion in SAD patients and healthy subjects matched with respect to age and sex. Int J Circumpolar Health 60:548–551PubMedGoogle Scholar
  31. 31.
    Kayumov L, Brown G, Jindal R, Buttoo K, Shapiro CM (2001) A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome. Psychosom Med 63:40–48PubMedGoogle Scholar
  32. 32.
    Kayumov L, Casper RF, Hawa RJ, Perelman B, Chung SA, Sokalsky S, Shapiro CM (2005) Blocking low-wavelength light prevents nocturnal melatonin suppression with no adverse effect on performance during simulated shift work. J Clin Endocrinol Metab 90:2755–2761PubMedCrossRefGoogle Scholar
  33. 33.
    Kayumov L, Lowe A, Rahman SA, Casper RF, Shapiro CM (2007) Prevention of melatonin suppression by nocturnal lighting: relevance to cancer. Eur J Cancer Prev 16:357–362PubMedCrossRefGoogle Scholar
  34. 34.
    Kayumov L, Zhdanova IV, Shapiro CM (2000) Melatonin, sleep, and circadian rhythm disorders. Semin Clin Neuropsychiatry 5:44–55PubMedGoogle Scholar
  35. 35.
    Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patents with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123PubMedGoogle Scholar
  36. 36.
    Lam RW (2006) Sleep disturbances and depression: a challenge for antidepressants. Int Clin Psychopharmacol 21(Suppl 1):S25–S29PubMedCrossRefGoogle Scholar
  37. 37.
    Lamond N, Dorrian J, Roach GD, McCulloch K, Holmes AL, Burgess HJ, Fletcher A, Dawson D (2003) The impact of a week of simulated night work on sleep, circadian phase, and performance. Occup Environ Med 60:e13PubMedCrossRefGoogle Scholar
  38. 38.
    Lamont EW, Legault-Coutu D, Cermakian N, Boivin DB (2007) The role of circadian clock genes in mental disorders. Dialogues Clin Neurosci 9:333–342PubMedGoogle Scholar
  39. 39.
    Lewy AJ, Bauer VK, Hasler BP, Kendall AR, Pires ML, Sack RL (2001) Capturing the circadian rhythms of free-running blind people with 0.5 mg melatonin. Brain Res 918:96–100PubMedCrossRefGoogle Scholar
  40. 40.
    Lockley SW, Skene DJ, James K, Thapan K, Wright J, Arendt J (2000) Melatonin administration can entrain the free-running circadian system of blind subjects. J Endocrinol 164:R1–R6PubMedCrossRefGoogle Scholar
  41. 41.
    Luebke JI, Greene RW, Semba K, Kamondi A, McCarley RW, Reiner PB (1992) Serotonin hyperpolarizes cholinergic low-threshold burst neurons in the rat laterodorsal tegmental nucleus in vitro. Proc Natl Acad Sci USA 89:743–747PubMedCrossRefGoogle Scholar
  42. 42.
    Lyness JM, Heo M, Datto CJ, Ten Have TR, Katz IR, Drayer R, Reynolds CF 3rd, Alexopoulos GS, Bruce ML (2006) Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. Ann Intern Med 144:496–504PubMedGoogle Scholar
  43. 43.
    Martin SK, Eastman CI (2000) When is your DLMO? Sleep 23:A179Google Scholar
  44. 44.
    Martin SK, Eastman CI (2002) Sleep logs of young adults with self-selected sleep times predict the dim light melatonin onset. Chronobiol Int 19:695–707PubMedCrossRefGoogle Scholar
  45. 45.
    Mendelson WB (1997) Efficacy of melatonin as a hypnotic agent. J Biol Rhythms 12:651–656PubMedCrossRefGoogle Scholar
  46. 46.
    Micale V, Arezzi A, Rampello L, Drago F (2006) Melatonin affects the immobility time of rats in the forced swim test: the role of serotonin neurotransmission. Eur Neuropsychopharmacol 16:538–545PubMedCrossRefGoogle Scholar
  47. 47.
    Mitani A, Ito K, Hallanger AE, Wainer BH, Kataoka K, McCarley RW (1988) Cholinergic projections from the laterodorsal and pedunculopontine tegmental nuclei to the pontine gigantocellular tegmental field in the cat. Brain Res 451:397–402PubMedCrossRefGoogle Scholar
  48. 48.
    Monteleone P, Fuschino A, Nolfe G, Maj M (1992) Temporal relationship between melatonin and cortisol responses to nighttime physical stress in humans. Psychoneuroendocrinology 17:81–86PubMedCrossRefGoogle Scholar
  49. 49.
    Nagtegaal E, Peeters T, Swart W, Smits M, Kerkhof G, van der Meer G (1998) Correlation between concentrations of melatonin in saliva and serum in patients with delayed sleep phase syndrome. Ther Drug Monit 20:181–183PubMedCrossRefGoogle Scholar
  50. 50.
    Pandi-Perumal SR, Srinivasan V, Spence DW, Cardinali DP (2007) Role of the melatonin system in the control of sleep: therapeutic implications. CNS Drugs 21:995–1018PubMedCrossRefGoogle Scholar
  51. 51.
    Partonen T, Treutlein J, Alpman A, Frank J, Johansson C, Depner M, Aron L, Rietschel M, Wellek S, Soronen P, Paunio T, Koch A, Chen P, Lathrop M, Adolfsson R, Persson ML, Kasper S, Schalling M, Peltonen L, Schumann G (2007) Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann Med 39:229–238PubMedCrossRefGoogle Scholar
  52. 52.
    Posener JA, DeBattista C, Williams GH, Chmura Kraemer H, Kalehzan BM, Schatzberg AF (2000) 24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. Arch Gen Psychiatry 57:755–760PubMedCrossRefGoogle Scholar
  53. 53.
    Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRefGoogle Scholar
  54. 54.
    Raghavendra V, Kulkarni SK (2000) Melatonin reversal of DOI-induced hypophagia in rats; possible mechanism by suppressing 5-HT(2A) receptor-mediated activation of HPA axis. Brain Res 860:112–118PubMedCrossRefGoogle Scholar
  55. 55.
    Rahman SA, Kayumov L, Tchmoutina EA, Shapiro CM (2009) Clinical efficacy of dim light melatonin onset testing in diagnosing delayed sleep phase syndrome. Sleep Med 10:549–555PubMedCrossRefGoogle Scholar
  56. 56.
    Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques, and scoring systems for sleep stages of human subjects. Brain Information/Brain Research Institute UCLA, Los Angeles, CAGoogle Scholar
  57. 57.
    Sack RL, Brandes RW, Kendall AR, Lewy AJ (2000) Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med 343:1070–1077PubMedCrossRefGoogle Scholar
  58. 58.
    Sack RL, Hughes RJ, Edgar DM, Lewy AJ (1997) Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms? Sleep 20:908–915PubMedGoogle Scholar
  59. 59.
    Sadek N, Bona J (2000) Subsyndromal symptomatic depression: a new concept. Depress Anxiety 12:30–39PubMedCrossRefGoogle Scholar
  60. 60.
    Shapiro CM, Auch C, Reimer M, Kayumov L, Heslegrave R, Huterer N, Driver H, Devins GM (2006) A new approach to the construct of alertness. J Psychosom Res 60:595–603PubMedCrossRefGoogle Scholar
  61. 61.
    Shirayama M, Shirayama Y, Iida H, Kato M, Kajimura N, Watanabe T, Sekimoto M, Shirakawa S, Okawa M, Takahashi K (2003) The psychological aspects of patients with delayed sleep phase syndrome (DSPS). Sleep Med 4:427–433PubMedCrossRefGoogle Scholar
  62. 62.
    Shiromani PJ, Armstrong DM, Berkowitz A, Jeste DV, Gillin JC (1988) Distribution of choline acetyltransferase immunoreactive somata in the feline brainstem: implications for REM sleep generation. Sleep 11:1–16PubMedGoogle Scholar
  63. 63.
    Skene DJ, Arendt J (2006) Human circadian rhythms: physiological and therapeutic relevance of light and melatonin. Ann Clin Biochem 43:344–353PubMedCrossRefGoogle Scholar
  64. 64.
    Souetre E, Salvati E, Belugou JL, Pringuey D, Candito M, Krebs B, Ardisson JL, Darcourt G (1989) Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res 28:263–278PubMedCrossRefGoogle Scholar
  65. 65.
    Srinivasan V, Smits M, Spence W, Lowe AD, Kayumov L, Pandi-Perumal SR, Parry B, Cardinali DP (2006) Melatonin in mood disorders. World J Biol Psychiatry 7:138–151PubMedCrossRefGoogle Scholar
  66. 66.
    Stehle J, Vanecek J, Vollrath L (1989) Effects of melatonin on spontaneous electrical activity of neurons in rat suprachiasmatic nuclei: an in vitro iontophoretic study. J Neural Transm 78:173–177PubMedCrossRefGoogle Scholar
  67. 67.
    Sun X, Deng J, Liu T, Borjigin J (2002) Circadian 5-HT production regulated by adrenergic signaling. Proc Natl Acad Sci USA 99:4686–4691PubMedCrossRefGoogle Scholar
  68. 68.
    Taylor GJ, Ryan D, Bagby RM (1985) Toward the development of a new self-report alexithymia scale. Psychother Psychosom 44:191–199PubMedCrossRefGoogle Scholar
  69. 69.
    Thompson C, Franey C, Arendt J, Checkley SA (1988) A comparison of melatonin secretion in depressed patients and normal subjects. Br J Psychiatry 152:260–265PubMedCrossRefGoogle Scholar
  70. 70.
    Torres-Farfan C, Richter HG, Rojas-Garcia P, Vergara M, Forcelledo ML, Valladares LE, Torrealba F, Valenzuela GJ, Seron-Ferre M (2003) mt1 melatonin receptor in the primate adrenal gland: inhibition of adrenocorticotropin-stimulated cortisol production by melatonin. J Clin Endocrinol Metab 88:450–458PubMedCrossRefGoogle Scholar
  71. 71.
    Trivedi MH, Rush AJ, Armitage R, Gullion CM, Grannemann BD, Orsulak PJ, Roffwarg HP (1999) Effects of fluoxetine on the polysomnogram in outpatients with major depression. Neuropsychopharmacology 20:447–459PubMedCrossRefGoogle Scholar
  72. 72.
    Tuunainen A, Kripke DF, Endo T (2004) Light therapy for non-seasonal depression. Cochrane Database Syst Rev: CD004050Google Scholar
  73. 73.
    Van Den Heuvel CJ, Reid KJ, Dawson D (1997) Effect of atenolol on nocturnal sleep and temperature in young men: reversal by pharmacological doses of melatonin. Physiol Behav 61:795–802CrossRefGoogle Scholar
  74. 74.
    Wahlund B, Grahn H, Saaf J, Wetterberg L (1998) Affective disorder subtyped by psychomotor symptoms, monoamine oxidase, melatonin and cortisol: identification of patients with latent bipolar disorder. Eur Arch Psychiatry Clin Neurosci 248:215–224PubMedCrossRefGoogle Scholar
  75. 75.
    Watanabe T, Kajimura N, Kato M, Sekimoto M, Nakajima T, Hori T, Takahashi K (2003) Sleep and circadian rhythm disturbances in patients with delayed sleep phase syndrome. Sleep 26:657–661PubMedGoogle Scholar
  76. 76.
    Wehr TA, Goodwin FK, Wirz-Justice A, Breitmaier J, Craig C (1982) 48-h sleep–wake cycles in manic-depressive illness: naturalistic observations and sleep deprivation experiments. Arch Gen Psychiatry 39:559–565PubMedGoogle Scholar
  77. 77.
    Wetterberg L (1979) Clinical importance of melatonin. Prog Brain Res 52:539–547PubMedCrossRefGoogle Scholar
  78. 78.
    Wetterberg L, Aperia B, Gorelick DA, Gwirtzman HE, McGuire MT, Serafetinides EA, Yuwiler A (1992) Age, alcoholism and depression are associated with low levels of urinary melatonin. J Psychiatry Neurosci 17:215–224PubMedGoogle Scholar
  79. 79.
    Wichniak A, Antczak J, Wierzbicka A, Jernajczyk W (2002) Alterations in pattern of rapid eye movement activity during REM sleep in depression. Acta Neurobiol Exp (Wars) 62:243–250Google Scholar
  80. 80.
    Wirz-Justice A (2006) Biological rhythm disturbances in mood disorders. Int Clin Psychopharmacol 21(Suppl 1):S11–S15PubMedCrossRefGoogle Scholar
  81. 81.
    Wirz-Justice A, Van den Hoofdakker RH (1999) Sleep deprivation in depression: what do we know, where do we go? Biol Psychiatry 46:445–453PubMedCrossRefGoogle Scholar
  82. 82.
    Wyatt JK, Dijk DJ, Ritz-de Cecco A, Ronda JM, Czeisler CA (2006) Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent. Sleep 29:609–618PubMedGoogle Scholar
  83. 83.
    Wyatt JK, Stepanski EJ, Kirkby J (2006) Circadian phase in delayed sleep phase syndrome: predictors and temporal stability across multiple assessments. Sleep 29:1075–1080PubMedGoogle Scholar
  84. 84.
    Yang CM, Spielman AJ, D’Ambrosio P, Serizawa S, Nunes J, Birnbaum J (2001) A single dose of melatonin prevents the phase delay associated with a delayed weekend sleep pattern. Sleep 24:272–281PubMedGoogle Scholar
  85. 85.
    Zisapel N (1999) The use of melatonin for the treatment of insomnia. Biol Signals Recept 8:84–89PubMedCrossRefGoogle Scholar
  86. 86.
    Zung W (1971) A rating instrument for anxiety disorders. Psychosomatics 12:371–379PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Shadab Ataur Rahman
    • 1
  • Shai Marcu
    • 2
    • 3
  • Leonid Kayumov
    • 2
  • Colin Michael Shapiro
    • 1
    • 2
    • 3
    • 4
    • 5
  1. 1.Sleep Research LaboratoryUniversity Health NetworkTorontoCanada
  2. 2.Department of PsychiatryUniversity of TorontoTorontoCanada
  3. 3.Youthdale Child and Adolescent Sleep CentreTorontoCanada
  4. 4.Department of OphthalmologyUniversity of TorontoTorontoCanada
  5. 5.Toronto Western HospitalTorontoCanada

Personalised recommendations